Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 01, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 169 $ 61
Trade and other receivables, net 15 106
Prepaid expenses and other current assets 102 394
Current assets from discontinued operations 0 8,612
Total current assets 286 9,173
Intangible assets - Soin, net 18,567 19,293
Other intangible assets, net 4 4
Note receivable - SPYR, net 9,377 8,974
Note receivable - VM7, net 5,718 0
Marketable securities 237 315
Deposits and other assets 17 18
Other assets from discontinued operations 0 8,979
Total assets 34,206 46,756
Liabilities:    
Accounts payable 2,402 2,276
Accrued liabilities - other 495 1,006
Short-term debt 0 274
Current liabilities from discontinued operations 0 20,382
Total current liabilities 2,897 23,938
Deferred income taxes, net 3,041 0
Other noncurrent liabilities 70 241
Noncurrent liabilities from discontinued operations 0 5,760
Total liabilities 6,008 29,939
Commitments and contingencies (Note 12)
Convertible preferred stock, series S - par value $0.001 per share, 200,000 authorized, 100,000 and 100,000 shares issued and outstanding at July 1, 2023 and December 31, 2022, respectively 14,510 14,510
Stockholders' equity:    
Preferred stock, series A-1 - par value $0.001 per share, 2,000,000 authorized, 209,706 and 222,588 shares issued and outstanding at July 1, 2023 and December 31, 2022, respectively 0 0
Common stock, par value $0.001 per share, 10,000,000 shares authorized, 3,768,878 and 2,827,410 shares issued and outstanding at July 1, 2023 and at December 31, 2022, respectively 3 2
Additional paid-in capital 46,299 45,748
Accumulated deficit (32,614) (42,822)
Accumulated other comprehensive loss 0 (621)
Total stockholders' equity 13,688 2,307
Total liabilities and stockholders' equity $ 34,206 $ 46,756